About HospiraNews & MediaInvestor RelationsIn the Community
Home




Hospira offers a wide range of ready-to-use and low-risk products in support of efforts to comply with the tighter controls on the compounding of sterile products required by USP Chapter <797>. These products include:

ADD-Vantage® System
FirstChoice® Premixes
Prefilled Syringes
    Carpuject® Syringe System
    Ansyr® Emergency Syringes
    LifeShield® Abboject® Emergency Syringes
    Prefilled Flush Syringes
Product Risk Comparison Chart

 

ADD-Vantage® System

According to the American Journal of Health-System Pharmacy:

“Another effective means of reducing the level of risk for CSPs [compounded sterile preparations] is the use of...unit-of-use closed transfer packaging (eg, Minibag Plus and ADD-Vantage).”1

The ADD-Vantage admixture system helps support USP <797> compliance efforts.

ADD-Vantage® System

  • Sterile components
  • Closed system
  • Activated just prior to administration

Back to Top

 

FirstChoice® Premixes

According to ASHP Guidelines: Minimum Standard for Pharmacies in Hospitals:

“Whenever possible, medications shall be available for inpatient use in single-unit packages and in a ready-to-administer form. Manipulation of medications before administration…should be minimized.”2

FirstChoice Premixes help answer the challenge to do more to avoid the potential for contamination during traditional admixing and therefore bolster any USP <797> compliance strategy. Hospira’s ready-to-use premixes are an excellent first choice for avoiding traditional admixing and the associated risks.

FirstChoice Premixes

  • No admixing
  • Convenient, ready to use
  • Avoids potential contamination that can occur during traditional admixing

Back to Top

   

Prefilled Syringes

According to the ASHP Guidelines on Preventing Medication Errors in Hospitals:

“Pharmacists should dispense medications in ready-to-administer dosage forms whenever possible. The unit-dose system is strongly recommended as the preferred method of drug distribution.”3

A USP <797> compliance strategy that includes medications in ready-to-administer dosage forms makes good sense. Prefilled syringes from Hospira can be an important part of that strategy.

Carpuject® Syringe System

  • Ready-to-use prefilled cartridges
  • Reduces risk because no preparation is necessary

Ansyr® and LifeShield® Abboject® Emergency Syringes

  • Prefilled
  • Ready to use, when seconds count

Prefilled Flush Syringes

  • Ready to use
  • Maintain IV lines while reducing potential contamination risk

Back to Top

 

Product Risk Comparison Chart

Hospira’s ready-to-use and low-risk products help support a
USP Chapter <797> compliance strategy.

References

1. Kastango ES, Bradshaw BD. USP chapter 797: establishing a practice standard for compounding sterile preparations in pharmacy. Am J Health Syst Pharm. 2004;61:1928-1938.

2. American Society of Health-System Pharmacists. ASHP guidelines: minimum standard for pharmacies in hospitals. In: Best Practices for Hospital & Health-System Pharmacy. Position & Guidance Documents of ASHP. 2004-2005 ed. Bethesda, Md: American Society of Health-System Pharmacists; 2004:325-330.

3. American Society of Health-System Pharmacists. ASHP guidelines on preventing medication errors in hospitals. In: Best Practices for Hospital & Health-System Pharmacy. Position & Guidance Documents of ASHP. 2004-2005 ed. Bethesda, Md: American Society of Health-System Pharmacists; 2004:155-163.

0